International Snakebite Awareness Day 2026
Every September 19, researchers, clinicians, public-health organizations, patient advocates and communities around the world mark International Snakebite Awareness Day.
Snakebite is one of the world's major neglected health problems, yet for much of modern public-health history it received remarkably little attention.
That has begun to change.
Today snakebite is recognized by the World Health Organization as a high-priority neglected tropical disease. Governments are developing national action plans. New antivenoms, engineered antibodies and small-molecule drugs are being investigated. Researchers are developing better ways to measure where bites occur and who dies from them. Community programs are improving prevention, first aid and access to treatment.
But International Snakebite Awareness Day 2026 arrives with an uncomfortable reminder of how much remains unknown: we may still be dramatically underestimating the number of people who die from snakebite every year.
How International Snakebite Awareness Day began
The first International Snakebite Awareness Day was held on September 19, 2018, launched by a coalition of organizations involved in tropical medicine, venom research, global health and snakebite advocacy.
Its founding partners included organizations such as the Royal Society of Tropical Medicine and Hygiene, Liverpool School of Tropical Medicine, Wellcome, Médecins Sans Frontières, the International Society on Toxinology, Instituto Clodomiro Picado and others. The aim was to give greater visibility to a health crisis that disproportionately affects poor, rural and agricultural communities in Africa, Asia, Latin America and parts of Oceania.
The timing was important.
In 2017, WHO had restored snakebite envenoming to its list of priority neglected tropical diseases. In May 2018, the World Health Assembly adopted resolution WHA71.5, calling for a coordinated global response to the problem. The following year WHO launched its Strategy for the Prevention and Control of Snakebite Envenoming, with the ambitious goal of reducing deaths and disability from snakebite by 50 percent by 2030.
International Snakebite Awareness Day became part of that larger shift: an annual opportunity to make an overwhelmingly rural and frequently invisible health problem visible.
What has changed since 2018?
The most important success may simply be that snakebite is no longer quite as invisible as it once was.
WHO now maintains a dedicated snakebite program and global strategy. Countries including India have created national programs and action plans. Researchers and clinicians working on snakebite are increasingly connected across institutions and continents. Better epidemiological studies are being conducted. Antivenom quality, regulation and distribution are receiving greater scrutiny.
Snakebite also increasingly appears in conversations about health-system capacity rather than simply as a problem of producing more antivenom.
That matters because surviving a dangerous snakebite can depend on an entire chain working correctly: recognizing the bite, using appropriate first aid, reaching medical care quickly, having trained clinicians available, having the correct treatment in stock, managing complications such as respiratory failure or kidney injury, and providing rehabilitation afterward.
WHO's global strategy reflects this broader approach through four priorities: empowering and engaging communities, ensuring safe and effective treatment, strengthening health systems, and increasing partnerships, coordination and resources.
There has also been meaningful progress at the other end of the treatment pipeline.
In February 2026, WHO published its first Target Product Profiles for novel snakebite therapeutics, providing guidance for the development of small-molecule drugs and engineered antibody treatments. Significantly, WHO developed separate profiles for therapies intended for hospital use and for treatments that might someday be given before a patient reaches a hospital—potentially buying crucial time after a bite.
Conventional animal-derived antivenoms remain the foundation of snakebite treatment, but after more than a century in which that basic treatment model has changed relatively little, the therapeutic landscape is beginning to broaden.
Snakebite Awareness Day in 2026
WHO's theme for International Snakebite Awareness Day 2026 is:
“Disabilities from snakebite envenoming: The Hidden Crisis.”
The campaign emphasizes that death is only part of the burden.
Survivors may experience amputations, chronic wounds, disfigurement, impaired mobility, nerve damage and other neurological problems. Psychological consequences can include anxiety, depression and post-traumatic stress. These disabilities can in turn produce loss of employment, debt, social exclusion and long-term effects on entire families.
WHO explicitly acknowledges that these consequences are severely underreported and calls for better measurement and long-term follow-up of snakebite survivors.
That emphasis is entirely justified, although it is worth noting that it is not new to 2026: WHO used essentially the same disability-focused campaign in both 2024 and 2025.
This year's international programming has also broadened the discussion. A September 17 webinar associated with the 2026 observance, “Connecting Climate, Communities and Care Through a One Health Approach,” examined snakebite in the context of environmental change, human behavior, community vulnerability and health-care access.
That reflects an important evolution in how the problem is understood. Snakebite is not merely an encounter between a person and a venomous animal. It occurs within landscapes shaped by agriculture, poverty, housing, transportation, climate, health infrastructure and human interaction with wildlife.
The numbers may be changing dramatically
The most consequential development surrounding Snakebite Awareness Day this year may have occurred several weeks before it.
On August 25, researchers published a major new analysis in PLOS Medicine reassessing the global burden of snakebite.
For years, WHO has cited an estimate of approximately 81,410 to 137,880 deaths annually, along with 1.8 to 2.7 million cases of envenoming. WHO's snakebite fact sheet, updated as recently as September 17, 2026, continues to use those figures.
The new study estimates something very different.
Using an updated literature review and geostatistical modelling, the researchers estimate at least 2.1 million envenomings and approximately 274,000 deaths every year. Their higher estimates reach approximately 7 million envenomings and 513,000 deaths annually.
Those numbers should be interpreted carefully. They are modelled estimates, and the authors themselves emphasize the scarcity and uneven quality of data from many of the countries most affected by snakebite.
But that limitation is also the point.
The study suggests that the global snakebite crisis may have been substantially underestimated precisely because many deaths occur in rural communities where patients never reach hospitals, deaths are poorly recorded, surveillance systems are incomplete, or reliable population-level studies have never been performed.
In other words, in 2026 we are not merely debating how to solve the global snakebite problem.
We are still trying to determine how large the problem actually is.
What International Snakebite Awareness Day has accomplished
Awareness days can easily become symbolic exercises: a logo, a hashtag and another date on the calendar.
International Snakebite Awareness Day has been more consequential than that.
It emerged during a period in which snakebite moved rapidly up the international public-health agenda. Since 2018 we have seen a WHO global strategy, increased funding and research activity, improved epidemiological work, greater attention to antivenom quality and access, new national programs, better community education and, increasingly, serious development of entirely new classes of treatment.
None of those developments can be credited to a single awareness campaign. They are the work of hundreds of researchers, physicians, health workers, governments, funders, NGOs and affected communities.
But visibility matters. Neglected diseases are neglected not because they are necessarily difficult to see, but because the people most affected by them often have very little political or economic visibility.
International Snakebite Awareness Day has helped change that.
Awareness is only the beginning
Snakebite is unusual among major global health problems.
We already know how to prevent many bites. We know that rapid medical treatment can save lives. Effective antivenoms already exist for many medically important snakes. Better products can be developed. Health workers can be trained. Transportation can be improved. New treatments are moving through research and clinical development.
This is not a problem waiting for a scientific miracle.
It is a problem of science, logistics, economics, health systems, geography and political attention—all operating at once.
International Snakebite Awareness Day was created because too few people knew that this crisis existed.
Eight years later, far more people do.
The next challenge is turning that awareness into systems capable of delivering the right treatment, to the right patient, in the right place, at the right time—and finally developing the data needed to understand whether the world is succeeding.